We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!

VMP 42184011000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Acrivastine 8mg capsules
BNF code 0304010A0AAAAAA
Virtual Therapeutic Moiety Acrivastine
Date identifier became valid 25 Aug 2023
Previous product identifier 320814008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Acrivastine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 8.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Acrivastine 8mg capsules (A A H Pharmaceuticals Ltd)
Acrivastine 8mg capsules (Alliance Healthcare (Distribution) Ltd)
Acrivastine 8mg capsules (Brown & Burk UK Ltd)
Allergy Relief 8mg capsules (Brown & Burk UK Ltd)
Benadryl Allergy Relief 8mg capsules (McNeil Products Ltd)
Virtual Medicinal Product Packs
Acrivastine 8mg capsules 12 capsule
Acrivastine 8mg capsules 24 capsule
Acrivastine 8mg capsules 48 capsule
Acrivastine 8mg capsules 84 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback